Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.68 USD | +1.30% | +8.58% | +44.44% |
03-20 | Canaccord Genuity Adjusts Price Target on Tenaya Therapeutics to $18 From $19, Maintains Buy Rating | MT |
03-19 | North American Morning Briefing : Stock Futures -2- | DJ |
Business Summary
Number of employees: 140
Managers
Managers | Title | Age | Since |
---|---|---|---|
Faraz Ali
CEO | Chief Executive Officer | 51 | 18-05-31 |
Leone Patterson
DFI | Director of Finance/CFO | 61 | 21-05-31 |
Kee-Hong Kim
CTO | Chief Tech/Sci/R&D Officer | - | 18-09-30 |
Chief Tech/Sci/R&D Officer | 56 | 18-11-30 | |
Chief Tech/Sci/R&D Officer | - | - | |
Timothy Hoey
CTO | Chief Tech/Sci/R&D Officer | 65 | 17-07-31 |
Michelle Corral
IRC | Investor Relations Contact | - | - |
Sunita Sethi
LAW | General Counsel | - | - |
Jennifer Drimmer
LAW | General Counsel | - | 22-01-09 |
Joanna Auch
HRO | Human Resources Officer | - | 21-12-21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Williams
BRD | Director/Board Member | 75 | 16-09-30 |
David Goeddel
CHM | Chairman | 72 | 16-07-31 |
Jeffrey Walsh
BRD | Director/Board Member | 58 | 20-02-29 |
Jin Long Chen
BRD | Director/Board Member | 61 | 16-09-30 |
Founder | 57 | 16-09-30 | |
Faraz Ali
CEO | Chief Executive Officer | 51 | 18-05-31 |
Karah Parschauer
BRD | Director/Board Member | 46 | 21-12-21 |
June Lee
BRD | Director/Board Member | 58 | 21-11-18 |
Director/Board Member | 61 | 20-05-31 | |
Amy Burroughs
BRD | Director/Board Member | 53 | 22-12-06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 78,517,534 | 77,177,932 ( 98.29 %) | 0 | 98.29 % |
Company contact information
Tenaya Therapeutics, Inc.
171 Oyster Point Boulevard 5th floor
94080, South San Francisco
+
http://www.tenayatherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.44% | 367M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- TNYA Stock
- Company Tenaya Therapeutics, Inc.